Abstract
Bacterial CNS infections comprise a wide spectrum of diseases, which may be acquired outside or inside the hospital, affect immunocompetent or immunocompromised patients, and be associated with trauma or procedures, as well as other exposures.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Kramer AH, Bleck TP. Neurocritical care of patients with central nervous system infections. Curr Infect Dis Rep. 2007;9(4):308–14.
Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med. 2004;32(7):1489–95.
Tunkel AR, Scheld WM. Acute meningitis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Elsevier; 2005. p. 1083–126.
Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care. 2004;1(2):219–33.
Angstwurm K, Reuss S, Freyer D, et al. Induced hypothermia in experimental pneumococcal meningitis. J Cereb Blood Flow Metab. 2000;20(5):834–8.
Cuthbertson BH, Dickson R, Mackenzie A. Intracranial pressure measurement, induced hypothermia and barbiturate coma in meningitis associated with intractable raised intracranial pressure. Anaesthesia. 2004;59(9):908–11.
Schwab S, Junger E, Spranger M, et al. Craniectomy: an aggressive treatment approach in severe encephalitis. Neurology. 1997;48(2):412–7.
Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743–8.
Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12(5):389–94.
Grimwood K, Anderson P, Anderson V, et al. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83(2):111–6.
Short WR, Tunkel AR. Changing epidemiology of bacterial meningitis in the United States. Curr Infect Dis Rep. 2000;2(4):327–31.
van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354(1):44–53.
van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849–59.
•• Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011;364(21):2016–25. This article provides an updated overview over epidemiology and pathogens of bacterial meningitis in the US over the past decade.
Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med. 1992;327(12):864–72.
Tunkel AR. Bacterial meningitis. Philadelphia: Williams & Wilkins; 2001.
Grandgirard D, Leib SL. Strategies to prevent neuronal damage in paediatric bacterial meningitis. Curr Opin Pediatr. 2006;18(2):112–8.
Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010;126(5):952–60.
Flores-Cordero JM, Amaya-Villar R, Rincón-Ferrari MD, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med. 2003;29(11):1967–73.
Wang KW, Chang WN, Chang HW, et al. The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure. 2005;14(8):586–92.
Wang KW, Chang WN, Chang HW, et al. Clinical relevance of hydrocephalus in bacterial meningitis in adults. Surg Neurol. 2005;64(1):61–5. discussion 66.
Weisfelt M, van de Beek D, Spanjaard L, et al. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006;5(2):123–9.
• Jim KK, Brouwer MC, van der Ende A, van de Beek D. Cerebral abscesses in patients with bacterial meningitis. J Infect. 2012;64(2):236–8. In this article, the most recent comprehensive analysis of features and occurrence of brain abscess in the setting of bacterial meningitis can be reviewed.
Bhimraj A. Acute community-acquired bacterial meningitis in adults: an evidence-based review. Cleve Clin J Med. 2012;79(6):393–400.
Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–92.
Michael B, Menezes BF, Cunniffe J, et al. Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults. Emerg Med J. 2010;27(6):433–8.
Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328(1):21–8.
Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267–84.
Huy NT, Thao NT, Diep DT, et al. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care. 2010;14(6):R240.
• Sakushima K, Hayashino Y, Kawaguchi T, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect. 2011;62(4):255–62. This article offers a comprehensive analysis and review of data available regarding laboratory distinction of different forms of meningitis by testing CSF lactate.
Brouwer MC, Thwaites GE, Tunkel AR, van de Beek D. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet. 2012;380(9854):1684–92.
Linder A, Akesson P, Brink M, et al. Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Crit Care Med. 2011;39(4):812–7.
Stahel PF, Nadal D, Pfister HW, et al. Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet. 1997;349(9069):1886–7.
Dubos F, Korczowski B, Aygun DA, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med. 2008;162(12):1157–63.
Proulx N, Frechette D, Toye B, et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005;98(4):291–8.
Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006;34(11):2758–65.
de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549–56.
van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010;9(3):254–63.
Assiri AM, Alasmari FA, Zimmerman VA, et al. Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysis. Mayo Clin Proc. 2009;84(5):403–9.
Vardakas KZ, Matthaiou DK, Falagas ME. Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta-analysis of randomized controlled trials. Eur J Neurol. 2009;16(6):662–73.
Lindvall P, Ahlm C, Ericsson M, et al. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis. 2004;38(3):384–90.
McIntyre PB, O’Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012;380(9854):1703–11.
Baltas I, Tsoulfa S, Sakellariou P, et al. Posttraumatic meningitis: bacteriology, hydrocephalus, and outcome. Neurosurgery. 1994;35(3):422–6. discussion 426–7.
Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of depressed cranial fractures. Neurosurgery. 2006;58(3 Suppl):S56–60. discussion Si–iv.
Tunkel AR, Turtz AR. Post-traumatic infections of the central nervous system. In: Evans RW, editor. Neurology and trauma. New York: Oxford Uniersity Press; 2006. p. 628–38.
van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146–54.
Ratilal B, Costa J, Sampaio C, Pappamikail L. Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD004884. doi:10.1002/14651858.CD004884.pub3.
Mathisen GE, Johnson JP. Brain abscess. Clin Infect Dis. 1997;25(4):763–79. quiz 780–1.
Nathoo N, Nadvi SS, Narotam PK, van Dellen JR. Brain abscess: management and outcome analysis of a computed tomography era experience with 973 patients. World Neurosurg. 2011;75(5–6):716–26. discussion 612–7.
Tsou TP, Lee PI, Lu CY, et al. Microbiology and epidemiology of brain abscess and subdural empyema in a medical center: a 10-year experience. J Microbiol Immunol Infect. 2009;42(5):405–12.
Gadgil N, Chamoun RB, Gopinath SP. Intraventricular brain abscess. J Clin Neurosci. 2012;19(9):1314–6.
Lambo A, Nchimi A, Khamis J, et al. Primary intraventricular brain abscess. Neuroradiology. 2003;45(12):908–10.
Manzar N, Manzar B, Kumar R, Bari ME. The study of etiologic and demographic characteristics of intracranial brain abscess: a consecutive case series study from Pakistan. World Neurosurg. 2011;76(1–2):195–200. discussion 79–83.
Carpenter J, Stapleton S, Holliman R. Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis. 2007;26(1):1–11.
Xiao F, Tseng MY, Teng LJ, et al. Brain abscess: clinical experience and analysis of prognostic factors. Surg Neurol. 2005;63(5):442–9. discussion 449–50.
Mampalam TJ, Rosenblum ML. Trends in the management of bacterial brain abscesses: a review of 102 cases over 17 years. Neurosurgery. 1988;23(4):451–8.
• Arlotti M, Grossi P, Pea F, et al. Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses. Int J Infect Dis. 2010;14 Suppl 4:S79–92. This article provides a consensus guideline approach to the topic of treatment of brain abscess.
Bayston R, de Louvois J, Brown EM, et al. Use of antibiotics in penetrating craniocerebral injuries. Infection in Neurosurgery Working Party of British Society for Antimicrobial Chemotherapy. Lancet. 2000;355(9217):1813–7.
Lee TH, Chang WN, Su TM, et al. Clinical features and predictive factors of intraventricular rupture in patients who have bacterial brain abscesses. J Neurol Neurosurg Psychiatry. 2007;78(3):303–9.
Kourbeti IS, Jacobs AV, Koslow M, et al. Risk factors associated with postcraniotomy meningitis. Neurosurgery. 2007;60(2):317–25. discussion 325–6.
McClelland 3rd S, Hall WA. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis. 2007;45(1):55–9.
Korinek AM, Baugnon T, Golmard JL, et al. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery. 2006;59(1):126–33. discussion 126–33.
Leib SL, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis. 1999;29(1):69–74.
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–55.
Lozier AP, Sciacca RR, Romagnoli MF, et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2008;62 Suppl 2:688–700.
Lozier AP, Sciacca RR, Romagnoli MF, Connolly Jr ES. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51(1):170–81. discussion 181–2.
Lyke KE, Obasanjo OO, Williams MA, et al. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33(12):2028–33.
Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310(9):553–9.
Hoefnagel D, Dammers R, Ter Laak-Poort MP, et al. Risk factors for infections related to external ventricular drainage. Acta Neurochir (Wien). 2008;150(3):209–14. discussion 214.
Chi H, Chang KY, Chang HC, et al. Infections associated with indwelling ventriculostomy catheters in a teaching hospital. Int J Infect Dis. 2010;14(3):e216–9.
Tse T, Cheng K, Wong K, et al. Ventriculostomy and infection: a 4-year-review in a local hospital. Surg Neurol Int. 2010;1:47.
Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85(3):419–24.
Arabi Y, Memish ZA, Balkhy HH, et al. Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control. 2005;33(3):137–43.
Stenehjem E, Armstrong WS. Central nervous system device infections. Infect Dis Clin North Am. 2012;26(1):89–110.
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.
Ross D, Rosegay H, Pons V. Differentiation of aseptic and bacterial meningitis in postoperative neurosurgical patients. J Neurosurg. 1988;69(5):669–74.
Schade RP, Schinkel J, Roelandse FW, et al. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg. 2006;104(1):101–8.
Pfausler B, Beer R, Engelhardt K, et al. Cell index – a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage? Acta Neurochir (Wien). 2004;146(5):477–81.
Wong GK, Poon WS, Ip M. Use of ventricular cerebrospinal fluid lactate measurement to diagnose cerebrospinal fluid infection in patients with intraventricular haemorrhage. J Clin Neurosci. 2008;15(6):654–5.
Sundbarg G, Nordstrom CH, Söderström S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg. 1988;2(4):485–95.
Camacho EF, Boszczowski I, Basso M, et al. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2011;39(1):47–51.
Scheithauer S, Burgel U, Bickenbach J, et al. External ventricular and lumbar drainage-associated meningoventriculitis: prospective analysis of time-dependent infection rates and risk factor analysis. Infection. 2010;38(3):205–9.
Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41(2):296–308.
Kethireddy S, Andes D. CNS pharmacokinetics of antifungal agents. Expert Opin Drug Metab Toxicol. 2007;3(4):573–81.
Tangden T, Enblad P, Ullberg M, Sjölin J. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis. 2011;52(11):1310–6.
Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother. 2008;61(2):461–2.
Kim BN, Peleg AY, Lodise TP, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis. 2009;9(4):245–55.
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
Korinek AM, Fulla-Oller L, Boch AL, et al. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8-year study. Neurosurgery. 2011;68(4):985–94. discussion 994–5.
Conen A, Walti LN, Merlo A, et al. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin Infect Dis. 2008;47(1):73–82.
Laxmi S, Tunkel AR. Healthcare-associated bacterial meningitis. Curr Infect Dis Rep. 2011;13(4):367–73.
Whitehead WE, Kestle JR. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg. 2001;35(4):205–10.
Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–32.
•• Leverstein-van Hall MA, Hopmans TE, van der Sprenkel JW, et al. A bundle approach to reduce the incidence of external ventricular and lumbar drain-related infections. J Neurosurg. 2010;112(2):345–53. This article features the changes in occurrence of EVD related infections with introduction of infection control by using a bundle approach.
Korinek AM, Reina M, Boch AL, et al. Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien). 2005;147(1):39–45. discussion 45–6.
Alleyne Jr CH, Hassan M, Zabramski JM. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery. 2000;47(5):1124–7. discussion 1127–9.
Poon WS, Ng S, Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl. 1998;71:146–8.
Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD005365. doi:10.1002/14651858.CD005365.pub2.
Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725–30.
Abla AA, Zabramski JM, Jahnke HK, et al. Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial. Neurosurgery. 2011;68(2):437–42. discussion 442.
Harrop JS, Sharan AD, Ratliff J, et al. Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery. 2010;67(1):187–91. discussion 191.
Stevens EA, Palavecino E, Sherertz RJ, et al. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. J Neurosurg. 2010;113(1):86–92.
Fichtner J, Guresir E, Seifert V, Raabe A. Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis. J Neurosurg. 2010;112(4):840–6.
Baer ET. Post-dural puncture bacterial meningitis. Anesthesiology. 2006;105(2):381–93.
Governale LS, Fein N, Logsdon J, Black PM. Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery. 2008;63(4 Suppl 2):379–84. discussion 384.
Piek J, Bock WJ. Continuous monitoring of cerebral tissue pressure in neurosurgical practice – experiences with 100 patients. Intensive Care Med. 1990;16(3):184–8.
Gelabert-Gonzalez M, Ginesta-Galan V, Sernamito-García R, et al. The Camino intracranial pressure device in clinical practice. Assessment in a 1000 cases. Acta Neurochir (Wien). 2006;148(4):435–41.
Martinez-Manas RM, Santamarta D, de Campos JM, Ferrer E. Camino intracranial pressure monitor: prospective study of accuracy and complications. J Neurol Neurosurg Psychiatry. 2000;69(1):82–6.
May AK, Fleming SB, Carpenter RO, et al. Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients. Surg Infect (Larchmt). 2006;7(5):409–17.
Poca MA, Sahuquillo J, Arribas M, et al. Fiberoptic intraparenchymal brain pressure monitoring with the Camino V420 monitor: reflections on our experience in 163 severely head-injured patients. J Neurotrauma. 2002;19(4):439–48.
Shapiro S, Bowman R, Callahan J, Wolfla C. The fiberoptic intraparenchymal cerebral pressure monitor in 244 patients. Surg Neurol. 1996;45(3):278–82.
Stoikes NF, Magnotti LJ, Hodges TM, et al. Impact of intracranial pressure monitor prophylaxis on central nervous system infections and bacterial multi-drug resistance. Surg Infect (Larchmt). 2008;9(5):503–8.
Morton R, Lucas 2nd TH, Ko A, et al. Intracerebral abscess associated with the Camino intracranial pressure monitor: case report and review of the literature. Neurosurgery. 2012;71(1):E193–8.
Fily F, Haegelen C, Tattevin P, et al. Deep brain stimulation hardware-related infections: a report of 12 cases and review of the literature. Clin Infect Dis. 2011;52(8):1020–3.
Vergani F, Landi A, Pirillo D, et al. Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease. World Neurosurg. 2010;73(4):338–44.
Gorgulho A, Juillard C, Uslan DZ, et al. Infection following deep brain stimulator implantation performed in the conventional versus magnetic resonance imaging-equipped operating room. J Neurosurg. 2009;110(2):239–46.
Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S51–61.
Zuger A. Tuberculosis. In: Scheld WM, Whitley RJ, Marra CM, editors. Infections of the central nervous system. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 441–60.
Chatterjee S. Brain tuberculomas, tubercular meningitis, and post-tubercular hydrocephalus in children. J Pediatr Neurosci. 2011;6 Suppl 1:S96–S100.
Pehlivanoglu F, Yasar KK, Sengoz G. Tuberculous meningitis in adults: a review of 160 cases. ScientificWorldJournal. 2012;2012:169028.
Kalita J, Misra UK, Ranjan P. Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. Eur J Neurol. 2007;14(1):33–7.
Sinner SW. Approach to the diagnosis and management of tuberculous meningitis. Curr Infect Dis Rep. 2010;12(4):291–8.
Moghtaderi A, Alavi-Naini R, Izadi S, Cuevas LE. Diagnostic risk factors to differentiate tuberculous and acute bacterial meningitis. Scand J Infect Dis. 2009;41(3):188–94.
Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci. 2000;181(1–2):118–26.
Lammie GA, Hewlett RH, Schoeman JF, Donald PR. Tuberculous cerebrovascular disease: a review. J Infect. 2009;59(3):156–66.
Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis. 2009;18(4):251–8.
Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 2002;360(9342):1287–92.
Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit. 2004;10(9):RA215–29.
Rafi W, Venkataswamy MM, Nagarathna S, et al. Role of IS6110 uniplex PCR in the diagnosis of tuberculous meningitis: experience at a tertiary neurocentre. Int J Tuberc Lung Dis. 2007;11(2):209–14.
Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003;3(10):633–43.
Wasay M, Kheleani BA, Moolani MK, et al. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. J Neuroimaging. 2003;13(3):240–7.
Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4(3):160–70.
American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1–77.
Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.
Takahashi T, Ogawa K, Sawada S, et al. A case of refractory tuberculous meningitis markedly improved by intrathecal administration of isoniazid (INH). Rinsho Shinkeigaku. 2003;43(1–2):20–5.
Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD002244. doi:10.1002/14651858.CD002244.pub3.
Torok ME, Yen NT, Chau TT, et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV) – associated tuberculous meningitis. Clin Infect Dis. 2011;52(11):1374–83.
Brancusi F, Farrar J, Heemskerk D. Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol. 2012;7(9):1101–16.
Tan EK, Chee MW, Chan LL, Lee YL. Culture positive tuberculous meningitis: clinical indicators of poor prognosis. Clin Neurol Neurosurg. 1999;101(3):157–60.
Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurol India. 2009;57(4):368–74.
Torok ME, Nguyen DB, Tran TH, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One. 2011;6(12):e27821.
Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML. Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery. 1994;35(4):622–31.
Lee GY, Daniel RT, Brophy BP, Reilly PL. Surgical treatment of nocardial brain abscesses. Neurosurgery. 2002;51(3):668–71. discussion 671–2.
Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7(2):213–64.
Barnicoat MJ, Wierzbicki AS, Norman PM. Cerebral nocardiosis in immunosuppressed patients: five cases. Q J Med. 1989;72(268):689–98.
Uttamchandani RB, Daikos GL, Reyes RR, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis. 1994;18(3):348–53.
Lerner PI. Nocardiosis. Clin Infect Dis. 1996;22(6):891–903. quiz 904–5.
Torres OH, Domingo P, Pericas R, et al. Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis. 2000;19(3):205–12.
Cianfoni A, Calandrelli R, De Bonis P, et al. Nocardia brain abscess mimicking high-grade necrotic tumor on perfusion MRI. J Clin Neurosci. 2010;17(8):1080–2.
Hall WA, Martinez AJ, Dummer JS, Lunsford LD. Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol. 1987;28(2):114–8.
Wallace Jr RJ, Steele LC, Sumter G, Smith JM. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988;32(12):1776–9.
Kilincer C, Hamamcioglu MK, Simsek O, et al. Nocardial brain abscess: review of clinical management. J Clin Neurosci. 2006;13(4):481–5.
Geiseler PJ, Andersen BR. Results of therapy in systemic nocardiosis. Am J Med Sci. 1979;278(3):188–94.
Smego Jr RA, Moeller MB, Gallis HA. Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med. 1983;143(4):711–8.
Obana WG, Rosenblum ML. Surgery for intracranial infections. In: Post KD, Friedman ED, McCormick P, editors. Postoperative complications in intracranial neurosurgery. New York: Thieme; 1993. p. 146–56.
US Department of Health and Human Services. Sexually transmitted disease surveillance. Atlanta, Georgia: Centers for Disease Control and Prevention; 2008. p. 2009.
Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep. 2003;5(2):145–52.
Hook 3rd EW, Marra CM. Acquired syphilis in adults. N Engl J Med. 1992;326(16):1060–9.
Tramont EC. Treponema pallidum (Syphilis). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Orlando, FL: Churchill Livingstone; 2005. p. 2768–84.
Simon RP. Neurosyphilis. Arch Neurol. 1985;42(6):606–13.
Kent ME, Romanelli F. Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother. 2008;42(2):226–36.
Ghanem KG. Review: Neurosyphilis: a historical perspective and review. CNS Neurosci Ther. 2010;16(5):e157–68.
Asdaghi N, Muayqil T, Scozzafava J, et al. The re-emergence in Canada of meningovascular syphilis: 2 patients with headache and stroke. CMAJ. 2007;176(12):1699–700.
Merritt HH. The early clinical and laboratory manifestations of syphilis of the central nervous system. New Engl J Med. 1940;223:446–50.
Gurses C, Bilgic B, Topçular B, et al. Clinical and magnetic resonance imaging findings of HIV-negative patients with neurosyphilis. J Neurol. 2007;254(3):368–74.
Harris DE, Enterline DS, Tien RD. Neurosyphilis in patients with AIDS. Neuroimaging Clin N Am. 1997;7(2):215–21.
• Chahine LM, Khoriaty RN, Tomford WJ, Hussain MS. The changing face of neurosyphilis. Int J Stroke. 2011;6(2):136–43. In this article, an updated view on neurosyphilis in the era of AIDS and HIV is provided, outlining the outdated prior presentations and featuring the new presentations of neurosyphilis.
Gaa J, Weidauer S, Sitzer M, et al. Cerebral vasculitis due to Treponema pallidum infection: MRI and MRA findings. Eur Radiol. 2004;14(4):746–7.
Flint AC, Liberato BB, Anziska Y, et al. Meningovascular syphilis as a cause of basilar artery stenosis. Neurology. 2005;64(2):391–2.
Vatz KA, Scheibel RL, Keiffer SA, Ansari KA. Neurosyphilis and diffuse cerebral angiopathy: a case report. Neurology. 1974;24(5):472–6.
Holmes MD, Brant-Zawadzki MM, Simon RP. Clinical features of meningovascular syphilis. Neurology. 1984;34(4):553–6.
Szilak I, Marty F, Helft J, Soeiro R. Neurosyphilis presenting as herpes simplex encephalitis. Clin Infect Dis. 2001;32(7):1108–9.
Romberg EH. Pupillary disturbances in tabes. Z Gesamte Neurol Psy. 1939;165:369–72.
Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med. 1990;113(11):872–81.
Ghanem KG, Moore RD, Rompalo AM, et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS. 2008;22(10):1145–51.
Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189(3):369–76.
Walter T, Lebouche B, Miailhes P, et al. Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis. 2006;43(6):787–90.
Bordon J, Martinez-Vazquez C, Alvarez M, et al. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 1995;14(10):864–9.
Berger JR. Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study. Arch Neurol. 1991;48(7):700–2.
Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2006;55(RR-11):1–94.
Centers for Disease Control and Prevention (CDC). Symptomatic early neurosyphilis among HIV-positive men who have sex with men – four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep. 2007;56(25):625–8.
Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003;290(11):1510–4.
Smith G, Holman RP. The prozone phenomenon with syphilis and HIV-1 co-infection. South Med J. 2004;97(4):379–82.
Davis LE, Schmitt JW. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol. 1989;25(1):50–5.
Marshall DW, Brey RL, Cahill WT, et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol. 1988;45(9):954–8.
Marra CM, Maxwell CL, Collier AC, et al. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis. 2007;7:37.
Bartt R. Listeria and atypical presentations of Listeria in the central nervous system. Semin Neurol. 2000;20(3):361–73.
Southwick FS, Purich DL. Intracellular pathogenesis of listeriosis. N Engl J Med. 1996;334(12):770–6.
Embil JA, Ewan EP, MacDonald SW. Surveillance of Listeria monocytogenes in human and environmental specimens in Nova Scotia, 1974 to 1981. Clin Invest Med. 1984;7(4):325–7.
Armstrong D. Listeria monocytogenes. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995. p. 1880–5.
Disson O, Lecuit M. Targeting of the central nervous system by Listeria monocytogenes. Virulence. 2012;3(2):213–21.
McLauchlin J. Human listeriosis in Britain, 1967–85, a summary of 722 cases. 2. Listeriosis in non-pregnant individuals, a changing pattern of infection and seasonal incidence. Epidemiol Infect. 1990;104(2):191–201.
Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore). 1998;77(5):313–36.
Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997;337(14):970–6.
Skogberg K, Syrjanen J, Jahkola M, et al. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis. 1992;14(4):815–21.
Watson GW, Fuller TJ, Elms J, Kluge RM. Listeria cerebritis: relapse of infection in renal transplant patients. Arch Intern Med. 1978;138(1):83–7.
Grotta J, Nelson W, Matocha J. Listeria encephalitis. Arch Neurol. 1981;38(3):200.
Harris JO, Marquez J, Swerdloff MA, Magana IA. Listeria brain abscess in the acquired immunodeficiency syndrome. Arch Neurol. 1989;46(3):250.
Dee RR, Lorber B. Brain abscess due to Listeria monocytogenes: case report and literature review. Rev Infect Dis. 1986;8(6):968–77.
Chu JY, Montanera W, Willinsky RA. Listeria spinal cord abscess – clinical and MRI findings. Can J Neurol Sci. 1996;23(3):220–3.
Armstrong RW, Fung PC. Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin Infect Dis. 1993;16(5):689–702.
Heck EF. Listeria monocytogenes. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology. Amsterdam: Elsevier Scientific; 1978. p. 77–95.
Uldry PA, Kuntzer T, Bogousslavsky J, et al. Early symptoms and outcome of Listeria monocytogenes rhombencephalitis: 14 adult cases. J Neurol. 1993;240(4):235–42.
Salgado MJ, Damani NN, Llewellyn CG, et al. Magnetic resonance imaging of abscesses of the brain stem and cerebellum complicating Listeria monocytogenes rhombencephalitis. Can Assoc Radiol J. 1996;47(6):431–3.
Lavetter A, Leedom JM, Mathies Jr AW, Ivler D, et al. Meningitis due to Listeria monocytogenes. A review of 25 cases. N Engl J Med. 1971;285(11):598–603.
Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med. 1997;336(10):708–16.
Rapp MF, Pershadsingh HA, Long Jr JW, Pickens JM. Ampicillin-resistant Listeria monocytogenes meningitis in a previously healthy 14-year-old athlete. Arch Neurol. 1984;41(12):1304.
Levitz RE, Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med. 1984;100(6):881–90.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Katharina M. Busl and Thomas P. Bleck declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Busl, K.M., Bleck, T.P. Bacterial Infections of the Central Nervous System. Curr Infect Dis Rep 15, 612–630 (2013). https://doi.org/10.1007/s11908-013-0384-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-013-0384-7